Entacapone

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 689 publications

From contested target to context-aware node: A three-layer regulatory code for interpreting FTO's oncogene-tumor suppressor paradox in cancer.

From contested target to context-aware node: A three-layer regulatory code for interpreting FTO's oncogene-tumor suppressor paradox in cancer.

Journal: Experimental cell research

Published: June 17, 2026

Identification of Entacapone as a Novel β-Arrestin 1 Biased Antagonist of CXCR7.

Identification of Entacapone as a Novel β-Arrestin 1 Biased Antagonist of CXCR7.

Journal: Molecules (Basel, Switzerland)

Published: June 17, 2026

Reduction-Alkylation Proteome Profiling (RAPP): A novel strategy for proteome-wide target identification.

Reduction-Alkylation Proteome Profiling (RAPP): A novel strategy for proteome-wide target identification.

Journal: Analytica chimica acta

Published: April 23, 2026

Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson's disease.

Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson's disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 26, 2026

Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Four-Period Crossover Study Under Fasting and Fed Conditions.

Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Four-Period Crossover Study Under Fasting and Fed Conditions.

Journal: Clinical pharmacology in drug development

Published: March 22, 2026

Prioritising medication management criteria to identify emergency department patients with potential medication-related harm: Nominal Group Technique workshops with clinicians.

Prioritising medication management criteria to identify emergency department patients with potential medication-related harm: Nominal Group Technique workshops with clinicians.

Journal: International journal of clinical pharmacy

Published: March 16, 2026

Uncovering MYOF as a novel therapeutic target in glioblastoma: mechanistic insights and drug discovery.

Uncovering MYOF as a novel therapeutic target in glioblastoma: mechanistic insights and drug discovery.

Journal: Cell death discovery

Published: February 28, 2026

Demographics, treatment patterns, and healthcare resource utilization in Parkinson's disease: a real-world data study using a claims database.

Demographics, treatment patterns, and healthcare resource utilization in Parkinson's disease: a real-world data study using a claims database.

Journal: Arquivos de neuro-psiquiatria

Published: January 25, 2026

Recent Developments in the Drug Treatment of Parkinson's Disease.

Recent Developments in the Drug Treatment of Parkinson's Disease.

Journal: Drugs

Published: January 15, 2026

CauReL: Dynamic Counterfactual Learning for Precision Drug Repurposing in Alzheimer's Disease.

CauReL: Dynamic Counterfactual Learning for Precision Drug Repurposing in Alzheimer's Disease.

Journal: Research square

Published: January 09, 2026

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Journal: Zeitschrift fur Gerontologie und Geriatrie

Published: December 19, 2025

Resolving spectral overlaps in Anti-Parkinson drug combinations: a green spectrophotometric approach for entacapone determination.

Resolving spectral overlaps in Anti-Parkinson drug combinations: a green spectrophotometric approach for entacapone determination.

Journal: BMC chemistry

Published: December 18, 2025

Showing 1-12 of 689

Last Updated: 09/26/2026